Domino concept idea of business risk, strategy and planning

Featured image: Jordan Lye/Getty Images

Distressed & Defaults

Leveraged loan default rate dips to 0.73%, but LMEs send dual-track gauge higher

The landscape for managing unsustainable debt burdens has shifted away from conventional defaults to out-of-court LMEs.

Want to see more? Fill out the form below.

I agree to PitchBook’s privacy policy

Restructuring activity among companies in the Morningstar LSTA US Leveraged Loan Index maintained a robust pace in April, with a missed payment, a bankruptcy filing and three distressed liability management exercises joining the fray.

As of April 30, the trailing 12-month default rates of the Morningstar LSTA US Leveraged Loan Index were as follows:

  • Payment default rate by amount: 0.73%
  • Payment default rate by issuer count: 1.23%
  • Dual-track default rate by issuer count: 4.38%

LCD’s monthly default report features the legacy payment default rate and a dual-track default rate by count that includes index issuers conducting distressed liability management exercises (LMEs). More details and the methodology can be found here.

Looking first at payment default trends, ConvergeOne and Xplornet Communications rolled off the trailing 12-month calculation. Two new additions left April’s payment default rate (excluding distressed LMEs) by issuer count unchanged from March, at 1.23%.

Defaults 1.png

The default rate by amount eased to 0.73% in April, from 0.82% in March. The April reading by amount is the lowest level for that metric since October 2024 and sits 102 bps below the post rate-hike cycle peak of 1.75% in July 2023.

The 10-year averages are 1.53% by amount and 1.67% by issuer count.

Defaults 2.png

When including the three distressed LMEs that prompted a downgrade to ‘D’ or ‘SD’ last month, the combined rate with payment defaults ticked higher, to 4.38% in April, from 4.31% in March. The combined rate hit a recent high of 4.70% in December 2024.

Looking specifically at distressed LMEs, with two departures and three additions, the trailing 12-month count of issuers in the Morningstar LSTA US Leveraged Loan Index conducting these out-of-court transactions edged up to 36 in April, from 35 in March and February. This compares to 28 in April 2024 and 12 in April 2023.

Defaults 3.png

Notably, the landscape for managing unsustainable debt burdens has shifted away from conventional defaults to out-of-court LMEs. As the preceding chart shows, the trailing 12-month count of LMEs has outpaced payment defaults and bankruptcies in every month since January 2024.

In 2023, defaults via interest payment misses or bankruptcy filings outnumbered LMEs in every single month of the year.

In terms of share of the restructuring landscape, for the 12 months ended April 30, LMEs made up 72% of the count, just shy of 73% in the February reading that set a new high watermark.

Defaults 4.png

By default
Looking at April’s defaults and restructurings, Ascend Performance added $1 billion of debt to the default rate when it filed for Chapter 11 in bankruptcy court in Houston on April 2. The loan issuer cited headwinds such as global economic malaise, reduced demand and increased competition out of China — each of which acutely impacted performance across Ascend’s business segments.

“Several of the key end markets for Ascend’s downstream and chemical intermediates businesses, including the manufacturing industry, have been slow to recover to pre-pandemic levels of production due to destocking, inflation, labor shortages, and supply chain issues,” Robert Del Genio, the company’s chief restructuring officer said in the first-day declaration filed with the court.

The company’s $1 billion senior secured term loan due August 2026 is a constituent of the Morningstar LSTA US Leveraged Loan Index.

Houston-based Ascend is a manufacturer of plastics, fibers and chemicals.

LCD also recorded a payment default for Fort Lauderdale, Fla.-based HealthChannels after it failed to repay its term loan that came due on April 3.

The provider of medical scribe programs struggled to rebound from the impact of reduced emergency department volumes during the pandemic lockdown, and its difficulties were further compounded by increased bill and wage rates and rising debt and refinancing costs. The company in 2023 engaged in a series of repurchases of the 2025 loan at distressed levels, prompting downgrades of the company to Selective Default and the loan to D at that time.

Cincinnati-based broadcasting company E.W. Scripps on April 10 completed a debt restructuring in which it exchanged its existing senior secured term loan B-2 due 2026 for a new senior secured term loan B-2 due 2028 and exchanged its senior secured term loan B-3 due 2028 for a new senior secured term loan B-3 due 2029.

S&P Global Ratings downgraded the issuer to Selective Default, and the targeted debt to D, citing lenders receiving less than originally promised, with the maturity extension of the term loan B-3 also behind the rating action.

“While the interest rate on the new term loan B-3 is 35 basis points (bps) higher than the existing term loan B-3 interest rate (Sofr + 300), we believe this rate is well below what the company would be required to pay for new capital under current market conditions and what an issuer with a similar risk profile would have to pay to raise new capital,” S&P said in its April 11 downgrade report.

Meanwhile, EagleView Technologies on April 28 received a downgrade to Selected Default at S&P Global Ratings and its outstanding debt was cut to D after the provider of aerial imagery completed a debt exchange with its lenders.

The company exchanged its existing $629 million first-lien term loan for a new $591 million first-lien term loan, swapped its $172 million second-lien term loan into an equivalent loan paying interest in-kind (PIK) and replaced its $85 million revolver with a new $42.5 million revolver.

All of EagleView’s debt maturities were extended to 2028, according to S&P, which determined current lenders are not being sufficiently compensated for the extended maturities and new subordination.

Finally, Thrive Pet Healthcare exchanged and extended its existing first- and second-lien term loan whereby approximately $188 million of the exchanged first-lien term has first-out priority — equal in ranking with the new RCF and new money term loan — with the remaining $1.3 billion of the exchanged first-lien loan having second-out priority.

The interest rate on the exchanged first-lien term loan, also an index constituent, was increased to Sofr+500 bps, with the second-out portion receiving an additional 200 bps of PIK interest.

As part of the refinancing, all of the loan maturities were extended to June 2028, and the exchanged first-lien term loan was granted an amortization holiday through maturity.

S&P on April 3 downgraded Pathway Vet Alliance LLC, dba Thrive Pet Healthcare, to Selective Default, from CCC+, following completion of the debt exchange, and also lowered the exchanged first-lien term loan to D, from CCC+.

“In our view, the transaction constitutes a shortfall relative to the original promise to both the first- and second-lien debt holders due to the delay in maturity, the subordination to the new money term loan, the amortization holiday, and the revision of interest payment,” S&P stated. The agency added that while the cash interest payment on the exchanged first-lien term loan is increasing by roughly 125 bps, ”we do not believe it offers sufficient compensation to adequately offset the other amended terms and weaker credit quality compared with the original transaction.”

Featured image: Jordan Lye/Getty Images

Learn about our editorial standards.